Squarepoint Ops »

Acrivon Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-06-30 $100k 17k 5.80

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Msci Brazil Etf Call Option (EWZ)
Tesla Motors Call Option (TSLA)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Sands Capital Ventures
Marshall Wace
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
DAFNA Capital Management
Northern Trust
Bridgeway Capital Management
Baker Bros. Advisors

View all funds holding Acrivon Therapeutics